
Ozempic is a prescription injectable medication used alongside diet and exercise to improve blood sugar control in adults with type 2 diabetes. It belongs to the glucagon-like peptide-1 (GLP-1) receptor agonist class and is widely trusted for both diabetes management and cardiovascular risk reduction.
Ozempic is administered once weekly using a pre-filled pen, offering a convenient alternative for patients who prefer fewer doses compared to daily medications.
Contact UsOzempic helps lower blood glucose levels and improve A1C by stimulating insulin release, reducing glucagon secretion, and slowing digestion after meals.
Ozempic is approved to reduce the risk of major adverse cardiovascular events, including heart attack, stroke, or cardiovascular-related death, in adults with type 2 diabetes and established heart disease.
Although Ozempic is not FDA-approved solely for weight loss, many patients experience significant weight reduction due to appetite suppression and delayed gastric emptying. Healthcare providers may recommend it when weight management is a clinical concern.